PMC:7464116 / 69564-69836 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T410","span":{"begin":24,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A410","pred":"fma_id","subj":"T410","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T219","span":{"begin":24,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A219","pred":"uberon_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T851","span":{"begin":24,"end":30},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T852","span":{"begin":24,"end":30},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T853","span":{"begin":24,"end":30},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T854","span":{"begin":70,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T855","span":{"begin":267,"end":270},"obj":"http://purl.obolibrary.org/obo/CLO_0054061"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T65","span":{"begin":117,"end":122},"obj":"Chemical"}],"attributes":[{"id":"A44102","pred":"chebi_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T417","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}

{"project":"2_test","denotations":[{"id":"32759645-32317402-58096258","span":{"begin":267,"end":270},"obj":"32317402"}],"text":"The Columbia University Kidney Transplant Program’s clinical practice has suggested to delay reintroduction of these drugs for up to 2 weeks after discharge, recognizing that prolonged reduction of immunosuppression therapy increases the risk of allograft rejection [132]."}